AMGLOBIA - Trademark Details
Status: 730 - First Extension - Granted
Serial Number
90160141
Word Mark
AMGLOBIA
Status
730 - First Extension - Granted
Status Date
2021-11-24
Filing Date
2020-09-04
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2021-04-20
Attorney Name
Law Office Assigned Location Code
N50
Employee Name
HOWELL, MATTHEW PATTER
Statements
Goods and Services
Blood plasma derivatives for medical purposes, namely, immune globulins including Rh immune globulin; Immunoglobulin preparations, namely, pharmaceutical immunoglobulin preparations for diagnosis of primary humoral immunodeficiency, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich syndrome, severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP), for preventing primary humoral immunodeficiency, Kawasaki disease, Guillain-Barre syndrome, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich syndrome and severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, cardiovascular disease, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP), and for treatment of primary humoral immunodeficiency, Kawasaki disease, Guillain-Barre syndrome, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich Syndrome and severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, cardiovascular disease, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP)
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-10-09
Primary Code
005
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Yoon S. Ham
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2020-09-08 | NEW APPLICATION ENTERED IN TRAM |
| 2020-10-09 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2021-01-12 | ASSIGNED TO EXAMINER |
| 2021-01-13 | PRIORITY ACTION WRITTEN |
| 2021-01-13 | PRIORITY ACTION E-MAILED |
| 2021-01-13 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| 2021-03-10 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2021-03-10 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-03-11 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-03-12 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-03-31 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2021-04-20 | PUBLISHED FOR OPPOSITION |
| 2021-04-20 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2021-06-15 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2021-11-24 | TEAS EXTENSION RECEIVED |
| 2021-11-24 | EXTENSION 1 FILED |
| 2021-11-24 | EXTENSION 1 GRANTED |
| 2021-11-26 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
